Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Oct 2021 for Intra-Cellular Therapies, Inc., €13k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Richard A. Lerner: trading record in brief
This profile gathers the share dealings of Richard A. Lerner in Intra-Cellular Therapies, Inc., where the filings describe the role as board member. We count 3 filings; the first trade dates from 31 December 2015 and the latest from 30 September 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 4 October 2021 came the latest disclosure, a share grant for €13k in Intra-Cellular Therapies, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard A. Lerner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
402 shares@ US$37.2850.6% of flowCommon StockSEC:0001209191-21-059104:0
367 shares@ US$40.8249.4% of flowCommon StockSEC:0001209191-21-045020:0
188 sharesCommon StockSEC:0001209191-16-088856:0
3 of 3 declarations
